-
1
-
-
0029047893
-
The Stockolm spinal cord injury study. I: Medical problems in a regional SCI population
-
Levi R, Hulting C, Nash MS, Seiger A. The Stockolm spinal cord injury study. I: medical problems in a regional SCI population. Paraplegia 1995; 33: 308-5.
-
(1995)
Paraplegia
, vol.33
, pp. 308-315
-
-
Levi, R.1
Hulting, C.2
Nash, M.S.3
Seiger, A.4
-
2
-
-
0023091260
-
Function limiting dysesthetic pain syndrome among traumatic SCI patients: A cross sectional study
-
Davidoff G, Roth E, Guarraccini M, Sliwa J, Yarcony G. Function limiting dysesthetic pain syndrome among traumatic SCI patients: a cross sectional study. Pain 1987; 29: 39-48.
-
(1987)
Pain
, vol.29
, pp. 39-48
-
-
Davidoff, G.1
Roth, E.2
Guarraccini, M.3
Sliwa, J.4
Yarcony, G.5
-
3
-
-
0030444120
-
Pain following spinal cord injury: The clinical problem and experimental studies
-
Yezierski RP. Pain following spinal cord injury: the clinical problem and experimental studies. Pain 1996; 68: 185-94.
-
(1996)
Pain
, vol.68
, pp. 185-194
-
-
Yezierski, R.P.1
-
4
-
-
0026783882
-
Baclofen reverses the hypersensitivity of dorsal hom wide dynamic range neurons to mechanical stimulation after transient spinal cord ischemia: Implications for a tonic GABAergic inhibitory control of myelinated fiber input
-
Hao JX, Xu XJ, Wiesenfeld-Hallin Z. Baclofen reverses the hypersensitivity of dorsal hom wide dynamic range neurons to mechanical stimulation after transient spinal cord ischemia: implications for a tonic GABAergic inhibitory control of myelinated fiber input. Neuropsychol 1992; 68: 392-6.
-
(1992)
Neuropsychol
, vol.68
, pp. 392-396
-
-
Hao, J.X.1
Xu, X.J.2
Wiesenfeld-Hallin, Z.3
-
5
-
-
0028173168
-
Intrathecal gamma-aminobutyric acid-beta (GABA-beta) receptor antagonist CGP 35348 induces hypersensitivity to mechanical stimuli in the rat
-
Hao JX, Xu XJ, Wiesenfeld-Hallin A. Intrathecal gamma-aminobutyric acid-beta (GABA-beta) receptor antagonist CGP 35348 induces hypersensitivity to mechanical stimuli in the rat. Neurosci Lett 1994; 182: 299-302.
-
(1994)
Neurosci Lett
, vol.182
, pp. 299-302
-
-
Hao, J.X.1
Xu, X.J.2
Wiesenfeld-Hallin, A.3
-
6
-
-
0027931856
-
Decreased GABA immunoreactivity in spinal cord dorsal hom neurons after transient spinal cord ischemia in the rat
-
Zhang AL, Hao JX, Seiger A et al. Decreased GABA immunoreactivity in spinal cord dorsal hom neurons after transient spinal cord ischemia in the rat. Brain Res 1994; 656: 187-90.
-
(1994)
Brain Res
, vol.656
, pp. 187-190
-
-
Zhang, A.L.1
Hao, J.X.2
Seiger, A.3
-
7
-
-
0029993650
-
Gabapentin adjunctive therapy in neuropathic pain states
-
Rosner H, Rubin L, Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain 1966; 12: 56-8.
-
(1966)
Clin J Pain
, vol.12
, pp. 56-58
-
-
Rosner, H.1
Rubin, L.2
Kestenbaum, A.3
-
8
-
-
0029795902
-
The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine
-
Singh L, Field MJ, Ferris P et al. The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacol 1996; 127: 1-9.
-
(1996)
Psychopharmacol
, vol.127
, pp. 1-9
-
-
Singh, L.1
Field, M.J.2
Ferris, P.3
-
9
-
-
0028999227
-
Gabapentin in the management of reflex sympathetic dystrophy
-
Mellick GA. Gabapentin in the management of reflex sympathetic dystrophy. J Pain Symptom Management 1995; 10: 265-6.
-
(1995)
J Pain Symptom Management
, vol.10
, pp. 265-266
-
-
Mellick, G.A.1
-
10
-
-
0028456066
-
Clinical pharmacokinetics of gabapentin
-
McLean MJ. Clinical pharmacokinetics of gabapentin. Neurology 1994; 44: S17-22.
-
(1994)
Neurology
, vol.44
-
-
McLean, M.J.1
-
11
-
-
0027454448
-
Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy
-
Goa KL, Sorkin EM. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy. Drugs 1993; 46: 409-27.
-
(1993)
Drugs
, vol.46
, pp. 409-427
-
-
Goa, K.L.1
Sorkin, E.M.2
-
12
-
-
0028864270
-
Gabapentin: Pharmacokinetics, efficacy, and safety
-
Beydoun A, Ultman BM, Sackellares JC. Gabapentin: pharmacokinetics, efficacy, and safety. Clin Neuropharmacol 1995; 18: 469-81.
-
(1995)
Clin Neuropharmacol
, vol.18
, pp. 469-481
-
-
Beydoun, A.1
Ultman, B.M.2
Sackellares, J.C.3
|